UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19161) 19161
Newsletter (317) 317
Newspaper Article (190) 190
Book Chapter (140) 140
Book / eBook (103) 103
Magazine Article (25) 25
Dissertation (13) 13
Conference Proceeding (9) 9
Web Resource (5) 5
Book Review (2) 2
Reference (2) 2
Paper (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17784) 17784
science & technology (13117) 13117
life sciences & biomedicine (12874) 12874
male (11864) 11864
female (11118) 11118
middle aged (9808) 9808
aged (8081) 8081
adult (7613) 7613
biological and medical sciences (6224) 6224
medical sciences (6214) 6214
otorhinolaryngology (5937) 5937
surgery (5165) 5165
head and neck neoplasms - surgery (4389) 4389
head and neck cancer (4332) 4332
oncology (4171) 4171
retrospective studies (3930) 3930
tumors (3805) 3805
aged, 80 and over (3290) 3290
cancer (3287) 3287
otorhinolaryngology. stomatology (3278) 3278
head and neck neoplasms - radiotherapy (3273) 3273
treatment outcome (3205) 3205
head and neck neoplasms - pathology (2958) 2958
radiotherapy (2707) 2707
abridged index medicus (2644) 2644
care and treatment (2589) 2589
head and neck neoplasms - complications (2467) 2467
surgery. transplantations, organ and tissue grafts. graft diseases (2051) 2051
follow-up studies (2038) 2038
adolescent (1944) 1944
medicine & public health (1932) 1932
head and neck neoplasms - therapy (1919) 1919
carcinoma, squamous cell - surgery (1761) 1761
head and neck surgery. maxillofacial surgery. dental surgery. orthodontics (1738) 1738
risk factors (1726) 1726
squamous cell carcinoma (1710) 1710
head & neck cancer (1704) 1704
research (1688) 1688
prognosis (1583) 1583
carcinoma, squamous cell - pathology (1559) 1559
chemotherapy (1527) 1527
radiology, nuclear medicine & medical imaging (1493) 1493
neoplasm staging (1480) 1480
analysis (1476) 1476
dentistry (1474) 1474
patients (1454) 1454
radiation therapy (1443) 1443
child (1333) 1333
neck (1330) 1330
prospective studies (1281) 1281
head and neck neoplasms - diagnosis (1280) 1280
dentistry, oral surgery & medicine (1263) 1263
combined modality therapy (1249) 1249
head (1240) 1240
head and neck neoplasms - drug therapy (1225) 1225
health aspects (1214) 1214
carcinoma, squamous cell - radiotherapy (1187) 1187
radiotherapy dosage (1179) 1179
postoperative complications (1168) 1168
head and neck (1142) 1142
tomography, x-ray computed (1121) 1121
surgery of the upper aerodigestive tract (1116) 1116
quality of life (1106) 1106
head and neck surgery (1099) 1099
young adult (1095) 1095
head and neck neoplasms - mortality (1093) 1093
magnetic resonance imaging (971) 971
reconstructive surgical procedures - methods (967) 967
hematology, oncology and palliative medicine (949) 949
neurosurgery (940) 940
head and neck neoplasms (938) 938
time factors (928) 928
surgical flaps (925) 925
otolaryngology (911) 911
survival rate (887) 887
radiation (870) 870
diagnosis (868) 868
squamous cell carcinoma of head and neck (864) 864
carcinoma, squamous cell - therapy (837) 837
carcinoma, squamous cell - mortality (830) 830
diagnosis, differential (804) 804
cancer patients (793) 793
radiotherapy - adverse effects (781) 781
metastasis (775) 775
cancer therapies (755) 755
upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology (750) 750
child, preschool (746) 746
complications and side effects (724) 724
medicine, research & experimental (722) 722
oncology, experimental (721) 721
medicine (720) 720
research & experimental medicine (720) 720
head and neck neoplasms - diagnostic imaging (718) 718
survival analysis (684) 684
papillomavirus infections - complications (678) 678
laryngeal neoplasms - surgery (672) 672
neck dissection (665) 665
radiology (662) 662
infant (658) 658
disease-free survival (636) 636
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (19) 19
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Dentistry (Harry R Abbott) - Stacks (4) 4
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Online Resources - Online (2) 2
Scarborough Hospital - General (2) 2
Scarborough Hospital - Online (2) 2
St. Michael's Hospital - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Dentistry (Harry R Abbott) - Circulation Desk (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19094) 19094
French (289) 289
German (247) 247
Spanish (138) 138
Italian (94) 94
Chinese (91) 91
Japanese (88) 88
Russian (78) 78
Portuguese (71) 71
Polish (56) 56
Czech (17) 17
Turkish (14) 14
Dutch (13) 13
Hungarian (12) 12
Croatian (9) 9
Romanian (9) 9
Danish (7) 7
Serbian (6) 6
Swedish (5) 5
Norwegian (4) 4
Korean (3) 3
Finnish (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Greek (1) 1
Hebrew (1) 1
Thai (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 11, pp. 1904 - 1911
pembrolizumab | autoimmune | nivolumab | elderly | ipilimumab | pediatrics | pregnancy | transplant | organ dysfunction | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Melanoma - complications | Age Factors | Humans | Immunosuppressive Agents - therapeutic use | Ipilimumab | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Hepatitis C, Chronic - complications | Transplant Recipients | Neoplasms - complications | Brain Neoplasms - secondary | Squamous Cell Carcinoma of Head and Neck | Pregnancy Complications, Neoplastic - drug therapy | Female | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - complications | Graft Rejection - prevention & control | Autoimmune Diseases - complications | Head and Neck Neoplasms - drug therapy | Brain Neoplasms - drug therapy | Lung Neoplasms - complications | Neoplasms - drug therapy | Pregnancy | Carcinoma, Non-Small-Cell Lung - complications | B7-H1 Antigen - antagonists & inhibitors | Carcinoma, Squamous Cell - drug therapy | Hepatitis B, Chronic - complications | Carcinoma, Squamous Cell - complications | Melanoma - drug therapy | Nivolumab | HIV Infections - complications | Head and Neck Neoplasms - complications | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Renal Cell - complications | Immunocompromised Host | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Virus diseases | Care and treatment | Dosage and administration | Research | Cell death | Immunosuppressive agents | Medical research | Brain | Populations | Toxicity | Decision making | Mortality | Disorders | Clinical trials | Cytotoxicity | Lymphocytes T | Metastasis | Patients | Regulatory approval | Metastases | Inhibitors | Immune checkpoint | Aggregates | Lymphocytes | Safety | Autoimmune diseases | Cancer | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 67, pp. 174 - 182
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Human papillomavirus | Survival | Chemoradiotherapy | Cisplatin | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - virology | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Case-Control Studies | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Aged, 80 and over | Adult | Female | Retrospective Studies | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - complications | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - complications | Hypopharyngeal Neoplasms - pathology | Radiotherapy, Conformal | Head and Neck Neoplasms - complications | Aged | Hypopharyngeal Neoplasms - complications | Neoplasm Staging | Laryngeal Neoplasms - complications | Laryngeal Neoplasms - virology | Radiotherapy, Intensity-Modulated | Papillomaviruses | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents | Papillomavirus infections | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 9, pp. 1566 - 1575
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1778 - 1790
human papillomavirus (HPV) | tumor necrosis factor receptor‐associated factor 3 (TRAF3) | prognosis | nuclear factor κB (NF‐κB) | head and neck squamous cell carcinoma | nuclear factor κB (NF-κB) | tumor necrosis factor receptor-associated factor 3 (TRAF3) | Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - genetics | Papillomavirus Infections - complications | Head and Neck Neoplasms - virology | Prognosis | Deubiquitinating Enzyme CYLD | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - virology | Humans | NF-kappa B - metabolism | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - metabolism | Oropharyngeal Neoplasms - complications | Papillomavirus Infections - genetics | Squamous Cell Carcinoma of Head and Neck | Papillomavirus Infections - metabolism | TNF Receptor-Associated Factor 3 - genetics | Carcinoma, Squamous Cell - complications | Tumor Suppressor Proteins - genetics | Oropharyngeal Neoplasms - metabolism | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - genetics | Papillomaviridae | Databases, Factual | Complications and side effects | Chemotherapy | Usage | Head and neck cancer | Diagnosis | Radiotherapy | Papillomavirus infections | Health aspects | Risk factors | Smoking | Cancer | Epidemics | Correlation | Genes | Radiation | Clinical trials | Genomes | Cancer therapies | Carcinogenesis | Defects | Incidence | Metastases | Carcinogens | Human papillomavirus | Etiology | Transcription activation | Tumorigenesis | Medical research | Integration | Head | Squamous cell carcinoma | Data processing | Oropharynx | Radiation therapy | Patients | Survival | Morbidity | Radiation dosage | Side effects | Tobacco | Lysine | Medical prognosis | Biomarkers | Head & neck cancer | Mutation | Cervical cancer | Tumors | Index Medicus | Abridged Index Medicus | Original
Journal Article
Auris, nasus, larynx, ISSN 0385-8146, 2016, Volume 44, Issue 1, pp. 98 - 103
Otolaryngology | Inverted papilloma | Squamous cell carcinoma | Sinonasal tract | Life Sciences & Biomedicine | Otorhinolaryngology | Science & Technology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Nose Neoplasms - complications | Neoplasms, Multiple Primary - therapy | Nose Neoplasms - diagnostic imaging | Aged, 80 and over | Maxillary Sinus Neoplasms - pathology | Paranasal Sinus Neoplasms - therapy | Nose Neoplasms - pathology | Head and Neck Neoplasms - diagnostic imaging | Tegafur - therapeutic use | Head and Neck Neoplasms - therapy | Nose Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Papilloma, Inverted - pathology | Head and Neck Neoplasms - pathology | Magnetic Resonance Imaging | Nasal Obstruction - etiology | Carcinoma, Squamous Cell - complications | Head and Neck Neoplasms - complications | Neoplasms, Multiple Primary - complications | Maxillary Sinus Neoplasms - therapy | Epistaxis - etiology | Maxillary Sinus Neoplasms - diagnostic imaging | Age Factors | Paranasal Sinus Neoplasms - diagnostic imaging | Carcinoma, Squamous Cell - diagnostic imaging | Papilloma, Inverted - diagnostic imaging | Neoplasms, Multiple Primary - diagnostic imaging | Chemoradiotherapy, Adjuvant | Fluorouracil - therapeutic use | Squamous Cell Carcinoma of Head and Neck | Nasal Cavity | Adult | Female | Retrospective Studies | Radiotherapy, Adjuvant | Papilloma, Inverted - complications | Kaplan-Meier Estimate | Otorhinolaryngologic Surgical Procedures | Neoplasms, Multiple Primary - pathology | Paranasal Sinus Neoplasms - complications | Disease-Free Survival | Maxillary Sinus Neoplasms - complications | Oxonic Acid - therapeutic use | Paranasal Sinus Neoplasms - pathology | Papilloma, Inverted - therapy | Aged | Neoplasm Staging | Drug Combinations | Medical records | Chemotherapy | Radiotherapy | College graduates | Cancer | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 11/2012, Volume 131, Issue 9, pp. 1969 - 1982
genital warts | screening | penile cancer | head and neck cancer | vulvar cancer | human papillomavirus | mortality | anal cancer | cervical cancer | incidence | HPV | vaccination | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Tumors | Female genital diseases | Humans | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Secondary Prevention | Papillomavirus Infections - therapy | Penile Neoplasms - epidemiology | Papillomaviridae - immunology | Vulvar Neoplasms - therapy | Head and Neck Neoplasms - epidemiology | Anus Neoplasms - therapy | Female | Anus Neoplasms - epidemiology | Uterine Cervical Neoplasms - therapy | Penile Neoplasms - therapy | Head and Neck Neoplasms - prevention & control | Papillomavirus Infections - complications | Primary Prevention | Early Detection of Cancer | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Head and Neck Neoplasms - therapy | Uterine Cervical Neoplasms - prevention & control | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Vulvar Neoplasms - epidemiology | Papillomavirus Vaccines - immunology | Medical colleges | Care and treatment | Vaccination | Oncology, Experimental | Research | College teachers | Prevention | Warts | Australians | Algorithms | Papillomavirus infections | Cervical cancer | Public health | Cancer | Human papillomavirus | Immunization | Infections | Disease | Medical screening | Index Medicus | head & neck cancer
Journal Article